Ubs Group Ag Iradimed Corp Transaction History
Ubs Group Ag
- $452 Billion
- Q3 2024
A detailed history of Ubs Group Ag transactions in Iradimed Corp stock. As of the latest transaction made, Ubs Group Ag holds 5,988 shares of IRMD stock, worth $327,244. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,988
Previous 4,728
26.65%
Holding current value
$327,244
Previous $207,000
45.41%
% of portfolio
0.0%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding IRMD
# of Institutions
140Shares Held
6.59MCall Options Held
0Put Options Held
0-
Nine Ten Capital Management LLC Evanston, IL906KShares$49.5 Million13.77% of portfolio
-
Black Rock Inc. New York, NY818KShares$44.7 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny539KShares$29.5 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA514KShares$28.1 Million0.0% of portfolio
-
Copeland Capital Management, LLC422KShares$23.1 Million0.38% of portfolio
About IRADIMED CORP
- Ticker IRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 12,565,100
- Market Cap $687M
- Description
- IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...